Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 01530 3SBIO > Detailed Quotes

01530 3SBIO

5.990
+0.420+7.54%
Closed 10/03 16:08 CCT
High
6.010
Open
5.550
Turnover
31.65M
Low
5.550
Pre Close
5.570
Volume
5.38M
Market Cap
14.61B
P/E(TTM)
7.11
52wk High
7.650
Shares
2.44B
P/E(Static)
7.23
52wk Low
4.520
Float Cap
14.61B
Bid/Ask %
-7.00%
Historical High
22.982
Shs Float
2.44B
Volume Ratio
0.66
Historical Low
4.520
Dividend TTM
0.2
Div Yield TTM
0.2
P/B
1.04
Dividend LFY
3.34%
Div Yield LFY
3.34%
Turnover Ratio
0.22%
Amplitude
8.26%
Avg Price
5.886
Lot Size
500
Float Cap
14.61B
Bid/Ask %
-7.00%
Historical High
22.982
Shs Float
2.44B
Volume Ratio
0.66
Historical Low
4.520
Dividend TTM
0.2
P/B
1.04
Dividend LFY
3.34%
Turnover Ratio
0.22%
Amplitude
8.26%
Avg Price
5.886
Lot Size
500
Price Forecast

No Data

News

Comment

Company Overview More
Sansheng Pharmaceutical is an investment holding company mainly engaged in the development, production, marketing and sales of pharmaceutical products. The company's main products include recombinant human thrombopoietin products, tumor necrosis factor-α inhibitors and recombinant human erythropoietin. The products are sold under the brands of Tebio, Yisep, iBio, and Cyber. The company sells products in the domestic market and overseas markets such as Sri Lanka, the Dominican Republic and Thailand. The company's subsidiaries include Jisi Co., Ltd., Hong Kong Sansheng Medical Co., Ltd. And Shenyang Sansheng Pharmaceutical Co., Ltd. The company is also engaged in project management and consulting through its subsidiaries.
CEO: Jing Lou
Market: Hong Kong motherboard
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...